Skip to content

Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial

Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012449
Enrollment
Unknown
Registered
2017-08-23
Start date
2015-09-25
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder

Interventions

group-based psychoeducation:pharmacological treatment and group-based psychoeducation
control group (regular free discussion):pharmacological treatment and combined regular free discussions

Sponsors

Beijing Anding hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Acute inpatients meeting the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V) diagnostic criteria for bipolar I disorder, manic episode; 2. At least 9 years of education; 3. Aged 16-60 years; 4. The informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Current dug or substance abuse or dependence; 2. Pregnant or lactating women; 3. Serious or unstable medical disease; 4. Mental retardation; 5. Accepting other interventional research.

Design outcomes

Primary

MeasureTime frame
Assessment of rehospitalization ;Assessment of recurrence rate;

Secondary

MeasureTime frame
Hamilton Depression Rating Score;young manic rating scale;WHO Disability Assessment Schedule 2.0;The Clinical Global Impressions (CGI) scale;Pharmacotherapy compliance ;

Countries

China

Contacts

Public ContactJiong Luo

Beijing Anding Hospital, Capital Medical University

luojiong2004@163.com+86 010 58303126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026